Cardiovascular diseases research in Vermont

What the 93.837–Vermont join records

Vermont as place of performance, Cardiovascular Diseases Research as the CFDA listing: 36 records summing to $77,070,293.62. It is not a patient census, a hospital list, or a named-PI roster. A large cell is easy to misread as named recipients; this packet publishes none. Campaign-finance filings do not pay these awards. Correlation is not causation.

Cardiovascular Diseases Research in Vermont is the both-keys table. CFDA 93.837 drops geography. Vermont federal spending drops the catalog. Vermont programs is the Vermont program index. All spending ties is the ties index. Use the overlay when both keys must stay on.

Cardiovascular research as a catalog line

Official title: CARDIOVASCULAR DISEASES RESEARCH. Mixing Cardiovascular Research with other disease-research catalog lines that use different CFDA numbers would invent a broader total. Facts available: Vermont, CFDA 93.837, $77,070,293.62, 36 awards. CARDIOVASCULAR DISEASES RESEARCH is the official title. Thirty-six awards is a research-scale file, not a count of patients. The join does not name universities, list trials, or convert obligations into procedures. Mixing this catalog with a services CFDA would invent a combined health total the packet never computed.

Vermont place of performance on 93.837

VT excludes New Hampshire, New York, and Massachusetts. Burlington, Montpelier, or Rutland folklore is a coding conversation, not a packet field. The geography tag does not convert $77,070,293.62 into a local scorecard. Neighbor-state joins for CFDA 93.837 are other pages.

Thirty-six awards, not thirty-six named patients

36 award actions sit behind $77,070,293.62. That row count can mix large instruments with smaller modifications. It is not 36 patients, hospitals, or investigators. Dividing $77,070,293.62 by 36 yields about $2,140,841.49 per award on average.

What cardiovascular research in Vermont omits

Keep $77,070,293.62 labeled as obligations in Vermont for Cardiovascular Diseases Research. It is not a clinic-outcome table or a trial registry. Outlays are unpublished. No fiscal year is published in this packet, so this page does not invent one.

Paths /states/vt/programs/93.837/, /programs/93.837/, /states/vt/, /states/vt/programs/, and /ties/ keep the same unit. A later ingest can restate $77,070,293.62 without changing the join definition of CFDA 93.837 × VT. Keep Cardiovascular Diseases Research and Vermont together when citing $77,070,293.62. CFDA 93.837 lists 36 award records on this VT join. Obligations of $77,070,293.62 are not outlays. Original filings remain on USAspending.gov for this CFDA 93.837 × VT pair. Do not add parent hubs into this state-program cell. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this Cardiovascular Diseases Research Vermont join. Agency splits are omitted from this packet. Quote CFDA 93.837, Vermont, and $77,070,293.62 in one sentence. The Vermont programs index and All spending ties index are larger than this cell. A later USAspending ingest can restate $77,070,293.62 without changing the join keys. This page is not a patient census, a hospital list, or a named-PI roster. 36 award records are not 36 patients, hospitals, or investigators. Mean dollars per action remain about $2,140,841.49 if you divide those two facts. VT is place of performance, not a split of Burlington, Montpelier, or Rutland. Keep Cardiovascular Diseases Research and Vermont together when citing $77,070,293.62. CFDA 93.837 lists 36 award records on this VT join. Obligations of $77,070,293.62 are not outlays. Original filings remain on USAspending.gov for this CFDA 93.837 × VT pair. Do not add parent hubs into this state-program cell. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this Cardiovascular Diseases Research Vermont join. Agency splits are omitted from this packet. Quote CFDA 93.837, Vermont, and $77,070,293.62 in one sentence. The Vermont programs index and All spending ties index are larger than this cell. A later USAspending ingest can restate $77,070,293.62 without changing the join keys. This page is not a patient census, a hospital list, or a named-PI roster.

Questions

How much cardiovascular research is obligated in Vermont?

USAspending.gov records $77,070,293.62 in CFDA 93.837 obligations with Vermont place of performance on 36 awards. That is the pair total, not an outlay and not a patient census, a hospital list, or a named-PI roster. Keep Cardiovascular Diseases Research and Vermont together when citing $77,070,293.62.

Do 36 awards mean 36 Vermont hospitals?

No. 36 is a USAspending award-record count, not 36 patients, hospitals, or investigators. The implied mean is about $2,140,841.49 per award. Unique recipients are unpublished. Obligations of $77,070,293.62 are not outlays. USAspending.gov remains the source for this 93.837 × VT pair.

Is this Vermont’s full federal health-research spend?

No. $77,070,293.62 is only the CFDA 93.837 × Vermont cell. Other catalogs appear on separate Vermont program pages. Nationwide 93.837 is not limited to Vermont. Mixing this listing with other disease-research catalog lines that use different CFDA numbers would invent a larger total.

Where is the live 93.837 × Vermont table?

Cardiovascular Diseases Research in Vermont is the overlay at /states/vt/programs/93.837/. CFDA 93.837 is /programs/93.837/. Vermont federal spending is /states/vt/. Vermont programs is /states/vt/programs/. All spending ties is /ties/. Original filings remain on USAspending.gov for this 93.837 × VT pair.